Giacomo Sgalla

1.7k total citations · 1 hit paper
47 papers, 1.1k citations indexed

About

Giacomo Sgalla is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Rheumatology. According to data from OpenAlex, Giacomo Sgalla has authored 47 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Pulmonary and Respiratory Medicine, 17 papers in Physiology and 7 papers in Rheumatology. Recurrent topics in Giacomo Sgalla's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (38 papers), Sarcoidosis and Beryllium Toxicity Research (14 papers) and Eosinophilic Disorders and Syndromes (7 papers). Giacomo Sgalla is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (38 papers), Sarcoidosis and Beryllium Toxicity Research (14 papers) and Eosinophilic Disorders and Syndromes (7 papers). Giacomo Sgalla collaborates with scholars based in Italy, United Kingdom and United States. Giacomo Sgalla's co-authors include Luca Richeldi, Francesco Varone, Bruno Iovene, Mariarosaria Calvello, Margherita Ori, Alice Biffi, Mark G. Jones, Alessia Comes, Jane A. Warner and Philipp Schneider and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, CHEST Journal and American Journal Of Pathology.

In The Last Decade

Giacomo Sgalla

39 papers receiving 1.1k citations

Hit Papers

Idiopathic pulmonary fibrosis: pathogenesis and management 2018 2026 2020 2023 2018 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Idiopathic pulmonary fibrosis: pathogenesis and management
    2018 413 citations Giacomo Sgalla, Bruno Iovene et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Giacomo Sgalla Italy 16 916 208 183 98 82 47 1.1k
George Margaritopoulos Greece 20 967 1.1× 312 1.5× 184 1.0× 158 1.6× 69 0.8× 47 1.2k
Antje Moeller Canada 4 1.0k 1.1× 142 0.7× 217 1.2× 96 1.0× 118 1.4× 6 1.3k
Yoshinori Tanino Japan 18 417 0.5× 203 1.0× 158 0.9× 163 1.7× 54 0.7× 65 966
Yutaka Hirasawa Japan 13 539 0.6× 196 0.9× 151 0.8× 136 1.4× 88 1.1× 27 874
Masanori Shiratori Japan 18 882 1.0× 192 0.9× 282 1.5× 109 1.1× 210 2.6× 33 1.2k
Katsushi Kurosu Japan 16 575 0.6× 240 1.2× 163 0.9× 106 1.1× 96 1.2× 53 1.0k
Michael J. Segel Israel 12 504 0.6× 67 0.3× 121 0.7× 49 0.5× 74 0.9× 35 741
Penny Lympany United Kingdom 19 426 0.5× 384 1.8× 203 1.1× 126 1.3× 57 0.7× 27 1.0k
Jane E. Parr United States 9 526 0.6× 73 0.4× 136 0.7× 77 0.8× 74 0.9× 10 702
Yueren Zhou United States 12 416 0.5× 107 0.5× 144 0.8× 297 3.0× 99 1.2× 29 988

Countries citing papers authored by Giacomo Sgalla

Since Specialization
Citations

This map shows the geographic impact of Giacomo Sgalla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giacomo Sgalla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giacomo Sgalla more than expected).

Fields of papers citing papers by Giacomo Sgalla

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giacomo Sgalla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giacomo Sgalla. The network helps show where Giacomo Sgalla may publish in the future.

Co-authorship network of co-authors of Giacomo Sgalla

This figure shows the co-authorship network connecting the top 25 collaborators of Giacomo Sgalla. A scholar is included among the top collaborators of Giacomo Sgalla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giacomo Sgalla. Giacomo Sgalla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Barney, Anna, Giacomo Sgalla, Simon Walsh, et al.. (2025). Automated system for diagnosing pulmonary fibrosis using crackle analysis in recorded lung sounds based on iterative envelope mean fractal dimension filter. Physiological Measurement. 46(2). 25003–25003.
2.
Iovene, Bruno, et al.. (2025). A Simple Ratio in a Complex Disease: Exploring the Neutrophil-to-Lymphocyte Ratio in Idiopathic Pulmonary Fibrosis. Journal of Clinical Medicine. 14(14). 5100–5100. 1 indexed citations
3.
4.
Mencarini, Paola, S. Carli, Carlotta Cerva, et al.. (2025). Usual Interstitial Pneumonia Pattern and Mycobacteria Lung Diseases: A Case Series. Infectious Disease Reports. 17(2). 28–28.
5.
Sofia, Carmelo, Alessia Comes, Giacomo Sgalla, & Luca Richeldi. (2024). Promising advances in treatments for the management of idiopathic pulmonary fibrosis. Expert Opinion on Pharmacotherapy. 25(6). 717–725. 6 indexed citations
6.
Varone, Francesco, Giuseppe Cicchetti, Bruno Iovene, et al.. (2024). Case of a 33-Year-Old Woman With Hemoptysis and Migrant Nodular Cavitary Lesions. CHEST Journal. 165(5). e133–e136. 1 indexed citations
7.
Comes, Alessia, et al.. (2023). Challenges in the diagnosis of idiopathic pulmonary fibrosis: the importance of a multidisciplinary approach. Expert Review of Respiratory Medicine. 17(4). 255–265. 6 indexed citations
8.
Sgalla, Giacomo, Paolo Maria Leone, Gina Gualano, et al.. (2023). A randomized trial of pamrevlumab in patients with COVID‐19 pneumonia. Respirology. 28(10). 954–957. 2 indexed citations
9.
Sofia, Carmelo, Alessia Comes, Giacomo Sgalla, & Luca Richeldi. (2023). An update on emerging drugs for the treatment of idiopathic pulmonary fibrosis: a look towards 2023 and beyond. Expert Opinion on Emerging Drugs. 28(4). 283–296. 7 indexed citations
10.
Sgalla, Giacomo, et al.. (2023). BI 1015550: an investigational phosphodiesterase 4B (PDE4B) inhibitor for lung function decline in idiopathic pulmonary fibrosis (IPF). Expert Opinion on Investigational Drugs. 32(1). 17–23. 11 indexed citations
11.
Sgalla, Giacomo, et al.. (2021). COVID-related fibrosis: insights into potential drug targets. Expert Opinion on Investigational Drugs. 30(12). 1183–1195. 7 indexed citations
12.
Sgalla, Giacomo, Alessia Comes, & Luca Richeldi. (2021). An updated safety review of the drug treatments for idiopathic pulmonary fibrosis. Expert Opinion on Drug Safety. 20(9). 1035–1048. 13 indexed citations
13.
Lorenzis, Enrico De, Silvia Laura Bosello, Francesco Varone, et al.. (2020). Multidisciplinary Evaluation of Interstitial Lung Diseases: New Opportunities Linked to Rheumatologist Involvement. Diagnostics. 10(9). 664–664. 19 indexed citations
14.
Sgalla, Giacomo, Anna Rita Larici, Mariarosaria Calvello, et al.. (2020). Mediastinal lymph node enlargement in idiopathic pulmonary fibrosis: relationships with disease progression and pulmonary function trends. BMC Pulmonary Medicine. 20(1). 249–249. 7 indexed citations
15.
16.
Varone, Francesco, Bruno Iovene, Giacomo Sgalla, et al.. (2020). Fibrotic Hypersensitivity Pneumonitis: Diagnosis and Management. Lung. 198(3). 429–440. 22 indexed citations
17.
Varone, Francesco, Giacomo Sgalla, Bruno Iovene, & Luca Richeldi. (2020). Progressive Fibrosing Interstitial Lung Disease. A Proposed Integrated Algorithm for Management. Annals of the American Thoracic Society. 17(10). 1199–1203. 4 indexed citations
18.
Sgalla, Giacomo, Simon Walsh, Sophie Fletcher, et al.. (2016). Validation of a Method for Automatic Detection of Lung Sounds in Fibrotic Interstitial Lung Disease. IRIS UNIMORE (University of Modena and Reggio Emilia). 193.
19.
Fletcher, Sophie, et al.. (2016). The safety of new drug treatments for idiopathic pulmonary fibrosis. Expert Opinion on Drug Safety. 15(11). 1483–1489. 15 indexed citations
20.
Jones, Mark G., Aurélie Fabre, Philipp Schneider, et al.. (2016). Three-dimensional characterization of fibroblast foci in idiopathic pulmonary fibrosis. JCI Insight. 1(5). 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by George Margaritopoulos Breakdown of academic impact, for papers by Antje Moeller Breakdown of academic impact, for papers by Yoshinori Tanino Breakdown of academic impact, for papers by Yutaka Hirasawa Breakdown of academic impact, for papers by Masanori Shiratori Breakdown of academic impact, for papers by Katsushi Kurosu Breakdown of academic impact, for papers by Michael J. Segel Breakdown of academic impact, for papers by Penny Lympany Breakdown of academic impact, for papers by Jane E. Parr Breakdown of academic impact, for papers by Yueren Zhou
Rankless by CCL
2026